We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
(-2.5%)
Cap. Flow
+$1.39B
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$532M |
| 2 |
Wells Fargo
WFC
|
+$480M |
| 3 |
Visa
V
|
+$435M |
| 4 |
Verizon
VZ
|
+$320M |
| 5 |
Broadcom
AVGO
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$547M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$498M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$456M |
| 5 |
Amazon
AMZN
|
+$445M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.66% |
| 2 | Technology | 16.35% |
| 3 | Healthcare | 16.13% |
| 4 | Consumer Discretionary | 11.2% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
CSX Corp
CSX
$98.6B
| $131M | 0.25% |
3,499,916
+2,923,521
| +507% | +$103M |
|
|
PDCE
77
DELISTED
PDC Energy, Inc.
PDCE
| $130M | 0.25% |
1,789,950
+271,553
| +18% | +$16.8M |
|
78
AstraZeneca
AZN
$263B
| $129M | 0.25% |
975,360
-43,965
| -4% | -$5.27M |
|
79
Linde
LIN
$237B
| $129M | 0.24% |
403,186
-712,505
| -64% | -$220M |
|
80
Procter & Gamble
PG
$343B
| $128M | 0.24% |
838,996
+788,444
| +1,560% | +$123M |
|
|
SPR
81
DELISTED
Spirit AeroSystems
SPR
| $126M | 0.24% |
2,567,691
-713,759
| -22% | -$33.4M |
|
82
Pfizer
PFE
$140B
| $123M | 0.23% |
2,366,989
-2,960,742
| -56% | -$154M |
|
83
Copa Holdings
CPA
$5.56B
| $122M | 0.23% |
1,461,311
+302,217
| +26% | +$24.9M |
|
84
Salesforce
CRM
$134B
| $121M | 0.23% |
570,396
+567,015
| +16,771% | +$122M |
|
85
Bio-Techne
TECH
$11.2B
| $121M | 0.23% |
1,116,468
-1,206,872
| -52% | -$125M |
|
86
CALL
Walmart Inc
WMT
$871B
| $120M | 0.23% |
+2,420,100
| New | +$114M |
|
87
PUT
SPDR Gold Trust
GLD
$131B
| $118M | 0.22% |
652,700
-354,800
| -35% | -$62.2M |
|
88
Phillips 66
PSX
$82.9B
| $118M | 0.22% |
1,360,517
+159,955
| +13% | +$13.5M |
|
|
89
Meta Platforms (Facebook)
META
$1.51T
| $117M | 0.22% |
527,085
-2,100,319
| -80% | -$525M |
|
90
Lam Research
LRCX
$382B
| $117M | 0.22% |
2,169,950
+1,627,550
| +300% | +$94.7M |
|
91
Teck Resources
TECK
$29.5B
| $116M | 0.22% |
+2,881,519
| New | +$103M |
|
92
Waste Management
WM
$95.9B
| $116M | 0.22% |
731,226
+541,669
| +286% | +$82.1M |
|
93
Diamondback Energy
FANG
$57.6B
| $114M | 0.22% |
833,137
+831,467
| +49,788% | +$108M |
|
94
Zoetis
ZTS
$31.6B
| $113M | 0.21% |
599,541
-543,252
| -48% | -$107M |
|
95
Arista Networks
ANET
$219B
| $112M | 0.21% |
3,236,404
+383,612
| +13% | +$12.1M |
|
96
Teladoc Health
TDOC
$1.58B
| $112M | 0.21% |
1,552,120
+1,114,090
| +254% | +$80.3M |
|
97
Bank of Montreal
BMO
$125B
| $112M | 0.21% |
948,121
+816,738
| +622% | +$94.7M |
|
98
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
| $107M | 0.2% |
1,556,039
+1,371,162
| +742% | +$99.9M |
|
99
Albemarle
ALB
$13.5B
| $107M | 0.2% |
482,729
+80,132
| +20% | +$16.9M |
|
|
CTXS
100
DELISTED
Citrix Systems Inc
CTXS
| $106M | 0.2% |
1,051,350
+1,004,005
| +2,121% | +$101M |
|
Similar funds
Marshall Wace's Q1 2022 Portfolio in Review
As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
- Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
- Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
- Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
- Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
- Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
- Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.
Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.